Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Dude51on May 03, 2021 10:31am

96 Views

Post# 33113708

MM's in action, what exchanges are green? Not VSX

ime ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
10:13:18	V	0.04		18,000	7 TD Sec	7 TD Sec	K
10:09:26	M	0.045	0.005	790	1 Anonymous	2 RBC
10:09:26	U	0.0425	0.0025	6,000	2 RBC	1 Anonymous	K
10:07:56	M	0.04		325	2 RBC	85 Scotia
10:07:56	U	0.04		5,000	1 Anonymous	85 Scotia	K
10:07:05	M	0.0425	0.0025	22,000	19 Desjardins	1 Anonymous
10:02:28	V	0.04		30,000	7 TD Sec	7 TD Sec	K
09:53:50	M	0.04		500	80 National Bank	89 Raymond James	E
09:53:50	U	0.04		5,000	1 Anonymous	89 Raymond James	K
09:48:22	X	0.04		4,000	1 Anonymous	79 CIBC	K